在急性心力衰竭中对酸盐过载的方法达成共识. 在SEMI/SEC/S.E.N.中使用. 建议建议建议建议建议建议
Pau Llàcer1, Gregorio Romero2, Joan Carles Trullàs3
1Servicio de Medicina Interna, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (Irycis), Madrid, Spain; Departamento de Medicina y Especialidades Médicas, Facultad de Medicina y Ciencias de la Salud, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain.
Revista espanola de cardiologia (English ed.)
|March 3, 2024
概括
在心力衰竭中管理液体过载对于疾病进展至关重要. 本文为住院和门诊患者提供了一种实用的治疗方法,整合了临床数据,成像和生物标志物.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内部医学 内部医学
背景情况:
- 流体过载是心力衰竭症状和疾病进展的主要驱动因素.
- 精确的诊断和有效的治疗液体过载存在重大临床挑战.
- 目前的指导方针建议采用多参数方法来管理流体过载.
研究的目的:
- 提出一种实用的治疗策略,用于管理心力衰竭患者的素过载.
- 为住院和门诊治疗流体过载提供指导.
- 巩固来自西班牙领先医学协会的专业知识.
主要方法:
- 审查目前关于心力衰竭中流体过载管理的建议.
- 整合临床数据,包括症状和征兆.
- 整合成像测试和生物标记数据.
- 开发一个实用的治疗算法.
主要成果:
- 概述了心力衰竭中素过载的综合治疗方法.
- 该方法涉及急性 (住院) 和慢性 (门诊) 治疗策略.
- 强调多参数评估,包括临床,成像和生物标记数据.
结论:
- 有效地管理素过载对于改善心力衰竭结果至关重要.
- 一个实用的,多参数的治疗策略可以在各种环境中增强患者的护理.
- 内科,心脏病学和科之间的合作是最佳管理的关键.
相关概念视频
Heart Failure Drugs: Diuretics
375
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
375
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
429
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
429
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Disorder of Water Balance
391
Water balance disorders are medical conditions that occur when there is a deviation from the body's water volume or osmolarity, disrupting normal homeostasis and leading todehydration, hypotonic hydration, hyperhydration, edema, or water intoxication.
Dehydration
Dehydration occurs when the body loses fluids (particularly water).
Causes:
The major causes of dehydration include excessive sweating, fever, vomiting, diarrhea, and diuresis.
Signs and Symptoms:
Symptoms primarily include intense...
Dehydration
Dehydration occurs when the body loses fluids (particularly water).
Causes:
The major causes of dehydration include excessive sweating, fever, vomiting, diarrhea, and diuresis.
Signs and Symptoms:
Symptoms primarily include intense...
391
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: β-Blockers
338
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
338


